3-aminobenzamide has been researched along with Carcinoma, Ehrlich Tumor in 6 studies
Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Exposure of Ehrlich ascites tumor cells to 3-aminobenzamide for 60 min resulted in a dose-dependent increase of cellular NAD and ATP levels at a concentration range of 0." | 1.28 | Influence of ADP-ribosyltransferase inhibitors on the intracellular NAD and ATP levels in Ehrlich ascites tumor cells: implication for the altered NAD + ATP-dependent cellular sensitivity to the cytotoxic agents. ( Drevenstedt, B; Hoshino, J; Kröger, H; Schalge, S, 1990) |
| " Thus cytogenetic damage induced by ASE plus 3-AB in vitro and by CBC, ASE, or CP plus 3-AB in vivo correlates well with 1) the prevention of NAD depletion in the presence of 3-AB in cells treated with the same alkylating agents in vitro or in vivo and 2) the in vivo antitumor effect by ASE, CBC, or CP in combination with 3-AB." | 1.28 | Effects of alkylating antineoplastics alone or in combination with 3-aminobenzamide on genotoxicity, antitumor activity, and NAD levels in human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo. ( Catsoulacos, P; Dozi-Vassiliades, J; Mioglou, E; Mourelatos, D; Petrou, C, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Hur, E | 1 |
| Kawamitsu, H | 1 |
| Miwa, M | 1 |
| Tanaka, Y | 1 |
| Sakamoto, H | 1 |
| Terada, M | 1 |
| Hoshi, A | 1 |
| Sugimura, T | 1 |
| Eliopoulos, P | 1 |
| Mourelatos, D | 2 |
| Dozi-Vassiliades, J | 2 |
| Hoshino, J | 1 |
| Schalge, S | 1 |
| Drevenstedt, B | 1 |
| Kröger, H | 1 |
| Petrou, C | 1 |
| Mioglou, E | 1 |
| Catsoulacos, P | 1 |
| Chen, G | 1 |
| Pan, QC | 1 |
1 review available for 3-aminobenzamide and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Involvement of poly (ADP-ribose) in the radiation response of mammalian cells.
Topics: Animals; Benzamides; Bleomycin; Carcinoma, Ehrlich Tumor; Cell Line; Cell Survival; Cricetinae; Cric | 1984 |
5 other studies available for 3-aminobenzamide and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Inhibitors of poly(adenosine diphosphate ribose) polymerase potentiate the antitumor activity of bleomycin against Ehrlich ascites carcinoma.
Topics: Animals; Benzamides; Bleomycin; Carcinoma, Ehrlich Tumor; Drug Synergism; Female; Mice; NAD+ Nucleos | 1982 |
Comparative study on Salmonella mutagenicity and on cytogenetic and antineoplastic effects induced by cyclophosphamide and 3-aminobenzamide in cells of three transplantable tumours in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carcinoma, Ehrlich Tumor; Cyclo | 1995 |
Influence of ADP-ribosyltransferase inhibitors on the intracellular NAD and ATP levels in Ehrlich ascites tumor cells: implication for the altered NAD + ATP-dependent cellular sensitivity to the cytotoxic agents.
Topics: Adenosine Triphosphate; Animals; Azacitidine; Benzamides; Carcinoma, Ehrlich Tumor; Female; Mice; Mi | 1990 |
Effects of alkylating antineoplastics alone or in combination with 3-aminobenzamide on genotoxicity, antitumor activity, and NAD levels in human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo.
Topics: Alkylating Agents; Animals; Benzamides; Carcinoma, Ehrlich Tumor; DNA Damage; DNA Repair; Humans; In | 1990 |
Potentiation of the antitumor activity of cisplatin in mice by 3-aminobenzamide and nicotinamide.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carcinoma, Ehrlich Tumor; Cispl | 1988 |